News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
AISLING CAPITAL III LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2018 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,400,000 shares
@ $179.43, valued at
$251.2M
|
|
| 12/20/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 250,000 shares
@ $80.5, valued at
$20.1M
|
|
| 11/27/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 500,000 shares
@ $75, valued at
$37.5M
|
|
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Converted 508,565 shares
@ $0
Bought 400,000 shares
@ $12.5, valued at
$5M
Converted 1,907,122 preferred shares
@ $0 |
|
| 06/03/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Disposed of 400,000 shares
@ $0 |
|
| 05/19/2016 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 232,558 shares
@ $21.5, valued at
$5M
|
|
| 12/15/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Bought 307,692 shares
@ $9.75, valued at
$3M
|
|
| 11/19/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 265,000 shares
@ $26.5, valued at
$7M
|
|
| 11/16/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Bought 76,714 shares
@ $27.6523, valued at
$2.1M
Bought 1,955 shares
@ $27.4702, valued at
$53.7k
|
|
| 01/29/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Versartis, Inc.|
Txns:
| Bought 145,000 shares
@ $17.25, valued at
$2.5M
|
|
| 01/27/2015 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Bought 811,966 shares
@ $5.85, valued at
$4.8M
|
|
| 08/14/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Converted 2,068,755 shares
@ $0
Bought 454,545 shares
@ $11, valued at
$5M
Converted 2,967,033 convertible preferred
@ $0
Converted 549,851 convertible preferred
@ $0 |
|
| 08/06/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Converted 2,850,709 shares
@ $0
Bought 413,077 shares
@ $13, valued at
$5.4M
Converted 2,343,749 convertible preferred
@ $0
Converted 506,960 convertible preferred
@ $0 |
|
| 05/22/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed of 745,730 shares
@ $0
Disposed of 3,528 shares
@ $0 |
|
| 04/23/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on TRANSENTERIX INC.|
Txns:
| Bought 1,037,767 shares
@ $4, valued at
$4.2M
|
|
| 03/27/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Versartis, Inc.|
Txns:
| Converted 35,104 shares
@ $0
Converted 1,236,715 shares
@ $0
Converted 128,695 shares
@ $0
Converted 56,939 shares
@ $0
Converted 477,115 shares
@ $0
Bought 60,000 shares
@ $21, valued at
$1.3M
Converted 403,704 convertible preferred
@ $0
Converted 14,222,222 convertible preferred
@ $0
Converted 1,479,993 convertible preferred
@ $0
Converted 654,796 convertible preferred
@ $0
Converted 5,486,820 convertible preferred
@ $0 |
|
| 03/21/2014 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Sold 98,000 shares
@ $15.7407, valued at
$1.5M
Sold 2,649 shares
@ $15.5738, valued at
$41.3k
|
|
| 01/27/2014 |
4
| SCHIFF ANDREW N (10% Owner) has filed a Form 4 on Zeltiq Aesthetics Inc|
Txns:
| Disposed of 994,305 shares
@ $0
Disposed of 4,715 shares
@ $0
Acquired 1,152 shares
@ $0
Acquired 4,697 shares
@ $0
Acquired 2,398 shares
@ $0 |
|
| 12/10/2013 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on TRANSENTERIX INC.|
Txns:
| Converted 12,401,764 shares
@ $0
Converted 1,240,176 preferred shares
@ $0 |
|
| 11/15/2013 |
4
| SCHIFF ANDREW N (10% Owner) has filed a Form 4 on Zeltiq Aesthetics Inc|
Txns:
| Sold 575,000 shares
@ $12.22, valued at
$7M
|
|
| 09/05/2013 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on SafeStitch Medical, Inc.|
Txns:
| Bought 1,240,176 preferred shares
@ $4, valued at
$5M
|
|
| 07/25/2012 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Converted 2,019,713 shares
@ $0
Bought 1,111,111 shares
@ $9, valued at
$10M
Converted 16,157,707 preferred shares
@ $0 |
|
| 10/25/2011 |
4
| SCHIFF ANDREW N (10% Owner) has filed a Form 4 on Zeltiq Aesthetics Inc|
Txns:
| Bought 769,231 shares
@ $13, valued at
$10M
|
|
|
|